Breaking News, Promotions & Moves

Lilly Forms Neuroscience and Immunology BUs

Makes executive leadership changes.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Eli Lilly and Co. has made executive leadership changes and created neuroscience and immunology business units. Effective September 5, Lilly Bio-Medicines will split into two business units: Lilly Neuroscience and Lilly Immunology.   Anne White, currently senior vice president and president of Lilly Oncology, will lead Lilly Neuroscience as senior vice president and president. Anne is an experienced leader in drug development who has led and grown Lilly’s oncology business over the past ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters